Suppr超能文献

HER2 结合亲和体分子 (Z(HER2∶342))₂ 增加 SKBR-3 细胞的放射敏感性。

The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.

机构信息

Department of Radiology, Oncology and Radiation Sciences, Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

出版信息

PLoS One. 2012;7(11):e49579. doi: 10.1371/journal.pone.0049579. Epub 2012 Nov 14.

Abstract

We have previously shown that the HER2-specific affibody molecule (Z(HER2∶342))₂ inhibits proliferation of SKBR-3 cells. Here, we continue to investigate its biological effects in vitro by studying receptor dimerization and clonogenic survival following irradiation. We found that (Z(HER2∶342))₂ sensitizes the HER2-overexpressing cell line SKBR-3 to ionizing radiation. The survival after exposure to (Z(HER2∶342))₂ and 8 Gy (S(8Gy) 0.006) was decreased by a factor four compared to the untreated (S(8Gy) 0.023). The low HER2-expressing cell line MCF-7 was more radiosensitive than SKBR-3 but did not respond to (Z(HER2∶342))₂. Treatment by (Z(HER2∶342))₂ strongly increased the levels of dimerized and phosphorylated HER2 even after 5 minutes of stimulation. The monomeric Z(HER2∶342) does not seem to be able to induce receptor phosphorylation and dimerization or sensitize cells to irradiation.

摘要

我们之前已经表明,HER2 特异性亲和体分子(Z(HER2∶342))抑制 SKBR-3 细胞的增殖。在这里,我们通过研究照射后受体二聚化和集落存活,继续在体外研究其生物学效应。我们发现,(Z(HER2∶342))使过表达 HER2 的 SKBR-3 细胞系对电离辐射敏感。与未处理组相比,暴露于(Z(HER2∶342))和 8 Gy(S(8Gy) 0.006)后,存活(S(8Gy) 0.023)降低了四倍。低表达 HER2 的 MCF-7 细胞系比 SKBR-3 更敏感,但对(Z(HER2∶342))没有反应。即使在刺激 5 分钟后,(Z(HER2∶342))的治疗也强烈增加了二聚化和磷酸化 HER2 的水平。单体 Z(HER2∶342)似乎不能诱导受体磷酸化和二聚化,也不能使细胞对辐射敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127d/3498194/f1d8ec4061d7/pone.0049579.g001.jpg

相似文献

1
The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cells.
PLoS One. 2012;7(11):e49579. doi: 10.1371/journal.pone.0049579. Epub 2012 Nov 14.
2
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line.
Biochem Biophys Res Commun. 2008 Dec 12;377(2):489-494. doi: 10.1016/j.bbrc.2008.10.027. Epub 2008 Oct 16.
3
Differences in radiosensitivity between three HER2 overexpressing cell lines.
Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1179-91. doi: 10.1007/s00259-007-0713-x. Epub 2008 Jan 12.
5
Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
J Nucl Med. 2013 Nov;54(11):1981-8. doi: 10.2967/jnumed.113.122465. Epub 2013 Oct 10.
6
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.
Biotechnol Appl Biochem. 2009 Aug 21;54(2):121-31. doi: 10.1042/BA20090096.
7
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
Cancer Res. 2007 Mar 15;67(6):2773-82. doi: 10.1158/0008-5472.CAN-06-1630.
9
Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule.
J Immunol Methods. 2008 Sep 30;338(1-2):1-6. doi: 10.1016/j.jim.2008.06.005. Epub 2008 Jul 29.

引用本文的文献

1
Encoding latent SuFEx reactive meta-fluorosulfate tyrosine to expand covalent bonding of proteins.
Chem Commun (Camb). 2022 Jun 14;58(48):6861-6864. doi: 10.1039/d2cc01902g.
2
Palladium-Mediated Incorporation of Carboranes into Small Molecules, Peptides, and Proteins.
J Am Chem Soc. 2022 May 4;144(17):7852-7860. doi: 10.1021/jacs.2c01932. Epub 2022 Apr 19.
4
Directed Evolution of Scanning Unnatural-Protease-Resistant (SUPR) Peptides for in Vivo Applications.
Chembiochem. 2016 Sep 2;17(17):1643-51. doi: 10.1002/cbic.201600253. Epub 2016 Jul 28.
5
Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy.
Theranostics. 2015 Jan 21;5(4):378-98. doi: 10.7150/thno.10084. eCollection 2015.

本文引用的文献

1
2
Structural basis for high-affinity HER2 receptor binding by an engineered protein.
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15039-44. doi: 10.1073/pnas.1005025107. Epub 2010 Aug 9.
4
Effects of an EGFR-binding affibody molecule on intracellular signaling pathways.
Int J Oncol. 2010 Apr;36(4):967-72. doi: 10.3892/ijo_00000576.
6
Receptor signaling as a regulatory mechanism of DNA repair.
Radiother Oncol. 2009 Sep;92(3):316-22. doi: 10.1016/j.radonc.2009.06.031. Epub 2009 Jul 15.
7
NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.
Radiat Res. 2009 Jan;171(1):9-21. doi: 10.1667/RR1472.1.
8
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line.
Biochem Biophys Res Commun. 2008 Dec 12;377(2):489-494. doi: 10.1016/j.bbrc.2008.10.027. Epub 2008 Oct 16.
9
Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
FEBS J. 2008 Jun;275(11):2668-76. doi: 10.1111/j.1742-4658.2008.06438.x. Epub 2008 Apr 24.
10
Differences in radiosensitivity between three HER2 overexpressing cell lines.
Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1179-91. doi: 10.1007/s00259-007-0713-x. Epub 2008 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验